DFCM
PTCT icon

Dark Forest Capital Management’s PTC Therapeutics PTCT Stock Holding History

Dark Forest Capital Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,347
Closed -$330K – 1073
2025
Q4 		$330K Buy
+4,347
New +$316K 0.02% 869
2025
Q3 		– Sell
-63,069
Closed -$3.08M – 1421
2025
Q2 		$3.08M Buy
63,069
+46,360
+277% +$2.2M 0.12% 259
2025
Q1 		$851K Buy
16,709
+7,072
+73% +$353K 0.04% 767
2024
Q4 		$435K Buy
9,637
+2,992
+45% +$128K 0.06% 500
2024
Q3 		$247K Buy
+6,645
New +$222K 0.03% 757
2023
Q1 		– Sell
-487
Closed -$18.6K – 1426
2022
Q4 		$18.6K Sell
487
-715
-59% -$29.7K ﹤0.01% 600
2022
Q3 		$60K Buy
1,202
+1,197
+23,940% +$58.6K 0.01% 506
2022
Q2 		$0 Buy
+5
New +$175 ﹤0.01% 1280
2021
Q4 		– Sell
-310
Closed -$12K – 1712
2021
Q3 		$12K Buy
+310
New +$12.7K ﹤0.01% 957

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Dark Forest Capital Management's PTCT Position: Q1 2026 in Review

Dark Forest Capital Management sold out of PTC Therapeutics (PTCT) in Q1 2026, closing a stake of 4,347 shares — an estimated $330K sold.

Dark Forest Capital Management first reported a position in PTCT in Q3 2021 and held it in 9 quarters. The position peaked at $3.08M in Q2 2025. 352 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Dark Forest Capital Management reported no remaining PTC Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Dark Forest Capital Management sold 4,347 PTC Therapeutics shares in Q1 2026, an estimated $330K.
  • Dark Forest Capital Management first reported a position in PTC Therapeutics in Q3 2021 and held it in 9 quarters.
  • Dark Forest Capital Management's PTC Therapeutics position peaked at $3.08M in Q2 2025.
  • 352 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.